<SEC-DOCUMENT>0000920465-17-000075-index.html : 20171030 <SEC-HEADER>0000920465-17-000075.hdr.sgml : 20171030 <ACCEPTANCE-DATETIME>20171027174839 ACCESSION NUMBER: 0000920465-17-000075 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20171026 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20171030 DATE AS OF CHANGE: 20171027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 171160350 BUSINESS ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>a2017q3earnings.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: a2017q3earnings.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>exhibit3q17.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: exhibit3q17.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>ljpcpressrelease_image1a10.jpg <TEXT> Document 3 - file: ljpcpressrelease_image1a10.jpg
</DOCUMENT> </SEC-DOCUMENT>